# Pfizer net income

entity: /record/pfizer.md  
predicate: net_income  
page: /record/pfizer/net_income  
as_of: 2026-11-10  
cite: AsOf. "Pfizer quarterly net income: 3,242,000,000 United States dollar", as of 2026-09-27. Claim clm_7B5F356BDB2E, https://asof.is/claim/clm_7B5F356BDB2E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/78003/000007800326000127/0000078003-26-000127-index.htm.  

As of November 10, 2026, the latest net income figure on the AsOf record for Pfizer is $3.24 billion for the quarter ended September 27, 2026, from a primary source (sec.gov). Pfizer's latest full-year net income is $7.77 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared.

19 claims on Pfizer's net income, 1 open and 18 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted.

## Latest net income

The newest figure for a shorter period, the quarter ended September 27, 2026: a quarterly_net_income claim, kept apart from the full-year series.

- [Pfizer](/record/pfizer.md) | quarterly_net_income | 3,242,000,000 United States dollar | valid 2026-09-27 to present | conf 0.95 | valid | [clm_7B5F356BDB2E](/claim/clm_7B5F356BDB2E.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800326000127/0000078003-26-000127-index.htm

## Latest full-year net income

What the record asserts on 2026-11-10.

- [Pfizer](/record/pfizer.md) | net_income | 7,771,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_B68A9D81D6E4](/claim/clm_B68A9D81D6E4.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/0000078003-26-000026-index.htm

## Every dated value

One claim per line, oldest first. Superseded claims stay visible.

- [Pfizer](/record/pfizer.md) | net_income | 8,144,000,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_C2718C858D30](/claim/clm_C2718C858D30.md) | [clm_F74BB34F06D8](/claim/clm_F74BB34F06D8.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000119312510042425/0001193125-10-042425-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 8,104,000,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_D31D477BB1ED](/claim/clm_D31D477BB1ED.md) | [clm_C2718C858D30](/claim/clm_C2718C858D30.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000119312510042425/0001193125-10-042425-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 8,635,000,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_F86870CAEBB2](/claim/clm_F86870CAEBB2.md) | [clm_D31D477BB1ED](/claim/clm_D31D477BB1ED.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000119312510042425/0001193125-10-042425-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 8,257,000,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_18F8E59667BA](/claim/clm_18F8E59667BA.md) | [clm_F86870CAEBB2](/claim/clm_F86870CAEBB2.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000119312511048877/0001193125-11-048877-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 10,009,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_4F864902CC25](/claim/clm_4F864902CC25.md) | [clm_18F8E59667BA](/claim/clm_18F8E59667BA.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000119312512085703/0001193125-12-085703-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 14,570,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_9C263899727D](/claim/clm_9C263899727D.md) | [clm_4F864902CC25](/claim/clm_4F864902CC25.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800313000006/0000078003-13-000006-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 22,003,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_2314E443626D](/claim/clm_2314E443626D.md) | [clm_9C263899727D](/claim/clm_9C263899727D.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800314000018/0000078003-14-000018-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 9,135,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_2F829FFC8699](/claim/clm_2F829FFC8699.md) | [clm_2314E443626D](/claim/clm_2314E443626D.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800315000014/0000078003-15-000014-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 6,960,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_85A65F179A0C](/claim/clm_85A65F179A0C.md) | [clm_2F829FFC8699](/claim/clm_2F829FFC8699.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800316000077/0000078003-16-000077-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 7,215,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_909812E45671](/claim/clm_909812E45671.md) | [clm_85A65F179A0C](/claim/clm_85A65F179A0C.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800317000014/0000078003-17-000014-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 21,308,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_E82040CDE79A](/claim/clm_E82040CDE79A.md) | [clm_909812E45671](/claim/clm_909812E45671.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800318000027/0000078003-18-000027-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 11,153,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_E9122BFE1E6C](/claim/clm_E9122BFE1E6C.md) | [clm_E82040CDE79A](/claim/clm_E82040CDE79A.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800319000015/0000078003-19-000015-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 16,273,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_A0FD17F0B861](/claim/clm_A0FD17F0B861.md) | [clm_E9122BFE1E6C](/claim/clm_E9122BFE1E6C.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800320000014/0000078003-20-000014-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 9,616,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_5D4C717AB3B8](/claim/clm_5D4C717AB3B8.md) | [clm_A0FD17F0B861](/claim/clm_A0FD17F0B861.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800321000038/0000078003-21-000038-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 21,979,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_8A832B97B4FD](/claim/clm_8A832B97B4FD.md) | [clm_5D4C717AB3B8](/claim/clm_5D4C717AB3B8.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800322000027/0000078003-22-000027-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 31,372,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_BE5DA6BB4EA3](/claim/clm_BE5DA6BB4EA3.md) | [clm_8A832B97B4FD](/claim/clm_8A832B97B4FD.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800323000024/0000078003-23-000024-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 2,119,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_9E891C94D652](/claim/clm_9E891C94D652.md) | [clm_BE5DA6BB4EA3](/claim/clm_BE5DA6BB4EA3.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800324000039/0000078003-24-000039-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 8,031,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_B68A9D81D6E4](/claim/clm_B68A9D81D6E4.md) | [clm_9E891C94D652](/claim/clm_9E891C94D652.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800325000054/0000078003-25-000054-index.htm
- [Pfizer](/record/pfizer.md) | net_income | 7,771,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_B68A9D81D6E4](/claim/clm_B68A9D81D6E4.md)
  sources: https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/0000078003-26-000026-index.htm

## What replaced what

- $8.14 billion (2007-12-31 to 2008-12-31, [clm_F74BB34F06D8](/claim/clm_F74BB34F06D8.md)) was replaced by $8.1 billion from 2008-12-31 ([clm_C2718C858D30](/claim/clm_C2718C858D30.md))
- $8.1 billion (2008-12-31 to 2009-12-31, [clm_C2718C858D30](/claim/clm_C2718C858D30.md)) was replaced by $8.64 billion from 2009-12-31 ([clm_D31D477BB1ED](/claim/clm_D31D477BB1ED.md))
- $8.64 billion (2009-12-31 to 2010-12-31, [clm_D31D477BB1ED](/claim/clm_D31D477BB1ED.md)) was replaced by $8.26 billion from 2010-12-31 ([clm_F86870CAEBB2](/claim/clm_F86870CAEBB2.md))
- $8.26 billion (2010-12-31 to 2011-12-31, [clm_F86870CAEBB2](/claim/clm_F86870CAEBB2.md)) was replaced by $10.01 billion from 2011-12-31 ([clm_18F8E59667BA](/claim/clm_18F8E59667BA.md))
- $10.01 billion (2011-12-31 to 2012-12-31, [clm_18F8E59667BA](/claim/clm_18F8E59667BA.md)) was replaced by $14.57 billion from 2012-12-31 ([clm_4F864902CC25](/claim/clm_4F864902CC25.md))
- $14.57 billion (2012-12-31 to 2013-12-31, [clm_4F864902CC25](/claim/clm_4F864902CC25.md)) was replaced by $22 billion from 2013-12-31 ([clm_9C263899727D](/claim/clm_9C263899727D.md))
- $22 billion (2013-12-31 to 2014-12-31, [clm_9C263899727D](/claim/clm_9C263899727D.md)) was replaced by $9.14 billion from 2014-12-31 ([clm_2314E443626D](/claim/clm_2314E443626D.md))
- $9.14 billion (2014-12-31 to 2015-12-31, [clm_2314E443626D](/claim/clm_2314E443626D.md)) was replaced by $6.96 billion from 2015-12-31 ([clm_2F829FFC8699](/claim/clm_2F829FFC8699.md))
- $6.96 billion (2015-12-31 to 2016-12-31, [clm_2F829FFC8699](/claim/clm_2F829FFC8699.md)) was replaced by $7.22 billion from 2016-12-31 ([clm_85A65F179A0C](/claim/clm_85A65F179A0C.md))
- $7.22 billion (2016-12-31 to 2017-12-31, [clm_85A65F179A0C](/claim/clm_85A65F179A0C.md)) was replaced by $21.31 billion from 2017-12-31 ([clm_909812E45671](/claim/clm_909812E45671.md))
- $21.31 billion (2017-12-31 to 2018-12-31, [clm_909812E45671](/claim/clm_909812E45671.md)) was replaced by $11.15 billion from 2018-12-31 ([clm_E82040CDE79A](/claim/clm_E82040CDE79A.md))
- $11.15 billion (2018-12-31 to 2019-12-31, [clm_E82040CDE79A](/claim/clm_E82040CDE79A.md)) was replaced by $16.27 billion from 2019-12-31 ([clm_E9122BFE1E6C](/claim/clm_E9122BFE1E6C.md))
- $16.27 billion (2019-12-31 to 2020-12-31, [clm_E9122BFE1E6C](/claim/clm_E9122BFE1E6C.md)) was replaced by $9.62 billion from 2020-12-31 ([clm_A0FD17F0B861](/claim/clm_A0FD17F0B861.md))
- $9.62 billion (2020-12-31 to 2021-12-31, [clm_A0FD17F0B861](/claim/clm_A0FD17F0B861.md)) was replaced by $21.98 billion from 2021-12-31 ([clm_5D4C717AB3B8](/claim/clm_5D4C717AB3B8.md))
- $21.98 billion (2021-12-31 to 2022-12-31, [clm_5D4C717AB3B8](/claim/clm_5D4C717AB3B8.md)) was replaced by $31.37 billion from 2022-12-31 ([clm_8A832B97B4FD](/claim/clm_8A832B97B4FD.md))
- $31.37 billion (2022-12-31 to 2023-12-31, [clm_8A832B97B4FD](/claim/clm_8A832B97B4FD.md)) was replaced by $2.12 billion from 2023-12-31 ([clm_BE5DA6BB4EA3](/claim/clm_BE5DA6BB4EA3.md))
- $2.12 billion (2023-12-31 to 2024-12-31, [clm_BE5DA6BB4EA3](/claim/clm_BE5DA6BB4EA3.md)) was replaced by $8.03 billion from 2024-12-31 ([clm_9E891C94D652](/claim/clm_9E891C94D652.md))
- $8.03 billion (2024-12-31 to 2025-12-31, [clm_9E891C94D652](/claim/clm_9E891C94D652.md)) was replaced by $7.77 billion from 2025-12-31 ([clm_B68A9D81D6E4](/claim/clm_B68A9D81D6E4.md))

## Questions this record answers

### What is Pfizer's current net income?

The latest figure on the record is $3.24 billion for the quarter ended September 27, 2026, from a primary source (sec.gov). The latest full-year figure is $7.77 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 10, 2026.

### What was Pfizer's net income for the quarter ended September 27, 2026?

$3.24 billion for the quarter ended September 27, 2026, dated September 27, 2026, from a primary source (sec.gov) (status valid, confidence 0.95).

### When did Pfizer's net income last change?

The latest value on the record is $7.77 billion, dated December 31, 2025; before it the record holds $8.03 billion, dated December 31, 2024 and closed on December 31, 2025.

### What was Pfizer's net income before $7.77 billion?

$8.03 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov).


## Read on

- This page: /record/pfizer/net_income (markdown: /record/pfizer/net_income.md)
- Entity twin: /record/pfizer.md · timeline: /timelines/pfizer.md
- Every company's net income: /facts/net_income.md

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
